Universal HIV Testing: Is It Enough?

Universal HIV testing: is it enough?

Early diagnosis of HIV infection and timely access to medical care can improve treatment outcomes [1] and potentially decrease the risk of transmission [2]. In this issue, Keruly and Moore [3] report a decrease in the presenting CD4 + T cell count from 371 cells/mm 3 in 1990–1994 to 276 cells/mm 3 in 2003–2006 among patients newly presenting for HIV care in a large academic center in the United...

Tackling HIV in MENA: Talk Is Not Enough–It Is Time for Bold Actions: A Response to Recent Commentaries

HIV testing in a high-incidence population: is antibody testing alone good enough?

BACKGROUND The Centers for Disease Control and Prevention recently recommended the expansion of human immunodeficiency virus (HIV) antibody testing. However, antibody tests have longer "window periods" after HIV acquisition than do nucleic acid amplification tests (NAATs). METHODS Public Health-Seattle & King County offered HIV antibody testing to men who have sex with men (MSM) using the Ora...

Improving lipid goal attainment: is it enough?

Lowering elevated levels of low-density lipoprotein cholesterol (LDL-C) is a surefire way to reduce cardiovascular risk. On the basis of a wealth of clinical trial evidence, guidelines from the National Cholesterol Education Program Adult Treatment Panel (ATP) have established progressively lower LDL-C targets, with the most recent iteration recommending an optional treatment goal of 70 mg/dL f...

Unenhanced Body MRA: Is it Good Enough?

Contrast-enhanced MR-Angiography (CE-MRA) has evolved into the standard, noninvasive imaging modality for vascular imaging of the body. It allows for high spatial resolution with submilimeter voxel sizes, a large field of view and it can be acquired in 15-25s. It relies on the administration of Gd-based contrast agent of which typically 0.2mmol/kg is administered. At 3.0T, the administered dose...